Novavax says vaccine is 90% effective against Covid-19
Novavax says its vaccine appears effective against COVID-19 in a large study, including against variants. "The major takeaways from the study are that we had overall, we had 90% efficacy, which is very high, particularly at a time when there are many variants circulating, in fact, mostly variant circulating during the trial," said Stanley Erck, the CEO of Novavax.
READ MORE:
Other Healthcare Videos
Stroke Pe Rok: How AI & Technology Are Revolutionising Stroke Care in India
Quad Cancer Moonshot: PM Modi announces USD 7.5 million support to fight cervical cancer
Mpox outbreak: WHO declares public health emergency of global concern
Study on Covaxin reports adverse events in some participants who took the Covid-19 vaccine
Covishield row: 'Very rare chances…', ex-AIIMS doctor explains severe side-effects of covid vaccine
